Pure Biologics at the Writing the Future of Drug Discovery and Development

Pure Biologics was invited to the event: "Writing the Future of Drug Discovery and Development", where it will present the first results of partnering with Twist Bioscience Corporation.

News

Inquiries

PB001 – completion of the first pilot preclinical study

30 August

2021

PB001 – completion of the first pilot preclinical study

Completion of the first preclinical pilot study in project PB001, in which Pure Biologics is developing a novel immunotherapy for the treatment of colorectal cancer.

Dr. Pieter Spee is the new Chief Scientific Officer

1 June

2021

Dr. Pieter Spee is the new Chief Scientific Officer

Dr. Pieter Spee, a medical biologist and manager with many years of experience in international biopharmaceutical companies, was appointed to the position of Chief Scientific Officer, CSO.

Recommendations for the Pure Biologics company shares

26 May

2021

Recommendations for the Pure Biologics company shares

Dom Maklerski BOŚ recommends the purchase of Pure Biologics shares.

Pure Biologics teams up with Twist Bioscience

15 April

2021

Pure Biologics teams up with Twist Bioscience

Pure Biologics joins efforts with Twist Bioscience to expand the capabilities of the phage display technology used in Pure Biologics' portfolio of immuno-oncology projects.

Project PB002 – preclinical research partner selected

19 March

2021

Project PB002 – preclinical research partner selected

Pure Biologics has selected a partner to lead the first panel of preclinical studies in the PB002 aptamer project

9 October

2020

Pure Biologics at the Writing the Future of Drug Discovery and Development

PB001 – completion of the first pilot preclinical study

Dr. Pieter Spee is the new Chief Scientific Officer

Recommendations for the Pure Biologics company shares

Pure Biologics teams up with Twist Bioscience

Project PB002 – preclinical research partner selected

Zapytanie Ofertowe – PB/MAGBBRIS/0/5/20 09.10.2020

Zapytanie Ofertowe – PB/MAGBBRIS/0/4/20 17.06.2020

Zapytanie Ofertowe – PB/MAGBBRIS/0/3/20 10.04.2020

Zapytanie Ofertowe – PB/MAGBBRIS/0/2/20 25.01.2020

Zapytanie Ofertowe – PB/MAGBBRIS/0/1/20 21.01.2020